Sputnik V, a human adenoviral vector vaccine candidate, is the world's first registered vaccine against COVID-19 and is now getting into the phase-3 trials in many countries this month.
According to sources, a couple of companies are considering manufacturing the Russian vaccine but companies like Shantha Biotech annd Bio E have not shown interest as they have their own vaccine candidates up for the bid.
Russian Direct Investment Fund have approached manufacturers in Hyderabad.
Russia became the first country in the world to launch a COVID-19 vaccine on August 12 when a vaccine prototype produced by Gamaleya Institute and the Russian defence ministry was registered successfully.
Sputnik V, a human adenoviral vector vaccine candidate, is the world's first registered vaccine against COVID-19 and is now getting into the phase-3 trials in many countries this month.
While Russia is already in touch with the Indian government regarding the manufacture and launch of Sputnik V in India, recent reports state that representatives of the Russian Direct Investment Fund have approached manufacturers in Hyderabad.
Hyderabad is already home to some big players in the vaccine industry like Biological Evans Shantha Biotechnics and Bharat Biotech. It also accounts for over a third of the global vaccine capacity.'
Hyderabad is already home to some big players in the vaccine industry like Biological Evans Shantha Biotechnics and Bharat Biotech. It also accounts for over a third of the global vaccine capacity.'
According to sources, a couple of companies are considering manufacturing the Russian vaccine but companies like Shantha Biotech annd Bio E have not shown interest as they have their own vaccine candidates up for the bid.
Approved in Russia last month, ‘Sputnik V’ passed early tests and produced an antibody response in all participants with no serious adverse effect results from early-phase non-randomised vaccine trials in a total of 76 people showed that two formulations of the vaccine have a good safety profile detected over 42 days, and induce antibody responses in all participants within 21 days.
The vaccine in question, 'Sputnik V' has been marred by controversies and speculations. Scientists and public health officials have been skeptical about Russian President Vladimir Putin’s claim that the country’s potential vaccine for the coronavirus “works quite effectively."